Adult Vaccines Market Valued At $37.5 Billion In 2026: Key Trends And Growth Drivers
Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Adult Vaccines Market Size And Revenue Outlook Through 2030
The adult vaccines market size has experienced strong growth in recent years. It is projected to expand from $24.21 billion in 2025 to $26.34 billion in 2026, at a compound annual growth rate (CAGR) of 8.8%. This historical growth can be ascribed to several factors, including the increasing prevalence of infectious diseases, government immunization initiatives, the development of novel vaccines, a growing geriatric population, and expanding healthcare infrastructure.
The adult vaccines market is projected to experience significant expansion over the coming years. This market is anticipated to reach $37.51 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.2%. Several factors are driving this projected growth, including progress in mRNA and recombinant vaccine technologies, greater investment in adult immunization initiatives, an increase in cold chain logistics capabilities, growing public understanding of vaccine-preventable illnesses, and strategic alliances between pharmaceutical and biotechnology firms. Key trends for the forecast period encompass heightened awareness of adult vaccination, the broadening scope of immunization programs, the creation of combination vaccines, an increase in vaccines for chronic disease management, and a surging need for vaccines related to travel and specific occupations.
Get A Free Sample Report With In-Depth Market Insights:
Adult Vaccines Market Demand Drivers: What’s Powering Industry Growth?
The expansion of the adult vaccine market was bolstered by a rise in healthcare spending. Healthcare expenditure is defined as the cumulative expense for health services delivered to a given population. Higher healthcare spending frequently translates into more substantial investment in medical research and development. Through investments in vaccination initiatives and improved vaccine accessibility, healthcare systems can lessen the impact of preventable illnesses and enhance public health generally. Furthermore, adult immunization offers considerable economic benefits by decreasing the demand for healthcare services and expensive medical interventions. For example, data from November 2023 by the Canadian Institute for Health Information, a Canada-based health company, estimated Canada’s total health expenditure for 2023 to hit $344 billion, marking an increase exceeding $9 billion from the 2022 figure. Consequently, the surge in healthcare expenditure had a beneficial effect on the expansion of the adult vaccine market.
Adult Vaccines Market Segments: Where Is Growth Concentrated?
The adult vaccines market covered in this report is segmented –
1) By Vaccine Type: Monovalent, Multivalent
2) By Technology: Live Attenuated Vaccines, Inactivated Viral Or Bacterial Vaccines, Toxoid Vaccines, Recombinant Vaccines, Conjugate Vaccines
3) By Application: Influenza, DPT, Human Papillomavirus, Zoster, Pneumococcal, Hepatitis
4) By End Users: Healthcare Firms, Hospitals
Subsegments:
1) By Monovalent: Single Antigen Vaccines, Specific Disease Vaccines
2) By Multivalent: Combination Vaccines, Multi-Antigen Vaccines
Adult Vaccines Market Innovation Trends: What Developments Are Reshaping The Industry?
Major companies within the adult vaccines market are prioritizing advancements in technology, particularly mRNA-based vaccines, to achieve rapid and precise immune responses. This focus aims to satisfy the growing need for adult immunization against respiratory diseases. An mRNA vaccine functions by enclosing messenger RNA within lipid nanoparticles, which then directs human cells to synthesize specific viral proteins, initiating an immune reaction without the use of live or attenuated viruses. For example, in May 2024, Moderna, a US-based biotechnology company, obtained FDA approval for mRESVI, an mRNA respiratory syncytial virus (RSV) vaccine intended for adults 60 years and older. This vaccine encodes the prefusion F glycoprotein of RSV and is delivered in single-dose, pre-filled syringes, enabling the production of neutralizing antibodies and offering improved safety and efficacy when compared to traditional inactivated or live-attenuated vaccines, thereby expanding adult immunization options.
Adult Vaccines Market Key Participants And Competitive Landscape
Major companies operating in the adult vaccines market are GlaxoSmithKline PLC, Merck & Co, Sanofi Pasteur, Pfizer Inc, Commonwealth Serum Laboratories Limited, Johnson & Johnson, Serum Institute of India, AstraZeneca PLC, Novartis AG, Protein Sciences Corporation, Emergent BioSolutions Inc., Bavarian Nordic A/S, Dynavax Technologies Corporation, Novavax Inc, Medimmune LLC, BioNTech SE, Moderna, Inovio Pharmaceuticals, Sinovac, Valneva Se, Biological E Limited, Panacea Biotec, Shenzhen Kangtai Biological Products, Beijing Tiantan Biological Products, Hualan Biological Engineering, Chengdu Institute of Biological Products, Bharat Biotech International Limited, Takeda Pharmaceutical Company Limited
View The Full Adult Vaccines Market Report:
Adult Vaccines Market Largest Region By Revenue And Market Share
North America was the largest region in the adult vaccines market in 2025. Asia-Pacific is expected to be the fastest-growing region in the adult vaccines market during the forecast period. The regions covered in the adult vaccines market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
